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Abstract
Chagas heart disease, caused by the protozoan parasite Trypanosoma cruzi, is a potentially fatal cardiomyopathy often
associated with cardiac autoimmunity. T. cruzi infection induces the development of autoimmunity to a number of antigens
via molecular mimicry and other mechanisms, but the genesis and pathogenic potential of this autoimmune response has
not been fully elucidated. To determine whether exposure to T. cruzi antigens alone in the absence of active infection is
sufficient to induce autoimmunity, we immunized A/J mice with heat-killed T. cruzi (HKTC) emulsified in complete Freund’s
adjuvant, and compared the resulting immune response to that induced by infection with live T. cruzi. We found that HKTC
immunization is capable of inducing acute cardiac damage, as evidenced by elevated serum cardiac troponin I, and that this
damage is associated with the generation of polyantigenic humoral and cell-mediated autoimmunity with similar antigen
specificity to that induced by infection with T. cruzi. However, while significant and preferential production of Th1 and Th17-
associated cytokines, accompanied by myocarditis, develops in T. cruzi-infected mice, HKTC-immunized mice produce lower
levels of these cytokines, do not develop Th1-skewed immunity, and lack tissue inflammation. These results demonstrate
that exposure to parasite antigen alone is sufficient to induce autoimmunity and cardiac damage, yet additional immune
factors, including a dominant Th1/Th17 immune response, are likely required to induce cardiac inflammation.
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Introduction
Chagas disease, along with African sleeping sickness and
leishmaniasis, is one of a triumvirate of diseases caused by
protozoan parasites belonging to the family Trypanosomatidae.
Chagas disease results from infection with Trypanosoma cruzi, which
is endemic to Central and South America [1]. Acutely, some
patients develop fatal myocarditis, some clear the infection with
minimal symptoms, and some develop a chronic infection leading
to an inflammatory cardiomyopathy termed Chagas heart disease
(CHD) [2]. Cardiac autoimmunity is among many contributing
factors proposed to explain the variable course and outcome of
CHD [3,4,5,6,7,8,9,10,11,12,13,14,15,16]. Although it is likely
that a combination of distinct mechanisms drives CHD patho-
genesis, the role of autoimmunity is of specific interest to our
laboratory to inform the design and application of new therapies.
The presence of cardiac autoimmunity is well documented in
mice and humans infected with T. cruzi [2,7,17,18,19,20]. There is
an ongoing debate regarding autoimmunity in CHD centered on
two major questions: By what mechanism(s) is autoimmunity
induced, and what role does autoimmunity play in disease
pathogenesis? CHD-related autoimmunity may be initiated by
parasite-induced damage to cardiomyocytes and/or by molecular
mimicry between immunologically similar epitopes of parasite and
host proteins. Cardiac myosin has been identified as a prominent
autoantigen in a variety of cardiac infectious/autoimmune
diseases, including CHD [5,18,21,22]. In models of experimental
autoimmune myocarditis (EAM), immunization with cardiac
myosin, recombinant myosin fragments, or myosin peptides
induces cardiac inflammation [23,24]. Even though a robust
autoimmune response against cardiac myosin is detected during T.
cruzi infection, our lab has shown through induction of antigen-
specific T-cell tolerance that myosin autoimmunity is not essential
for cardiac inflammation in acute CHD [25]. However, using a
different strategy of immunologic tolerance induction, Pontes-de-
Carvalho and colleagues were able to successfully prevent
autoimmune myocarditis in mice chronically infected with T.
cruzi by tolerizing with an emulsion of cardiac homogenate
containing myosin, actin, and numerous other unidentified cardiac
proteins [26]. Together these results indicate that autoimmunity
may contribute to CHD pathogenesis, but that autoreactive
immune responses to proteins other than myosin are required for
the induction of autoimmune myocarditis in experimental CHD.
We have previously demonstrated that immunization with T. cruzi
protein extract in CFA induced cross-reactive humoral and
cellular autoimmunity against cardiac myosin, but did not induce
myocarditis [27]. This suggested that while molecular mimicry
between T. cruzi antigens and cardiac myosin occurs, T. cruzi
antigen-induced autoimmunity may not be sufficient to drive
myocarditis, although the mechanisms underlying this disconnect
were not apparent. It remains unclear how immunization with
myosin or myosin fragments initiates autoimmunity with associ-
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only autoimmunity. Importantly, the spectrum and type of the
cellular immune response was not thoroughly examined in
previous studies, leaving important unanswered questions regard-
ing the role autoimmunity might play in CHD pathogenesis.
Immunity to cardiac autoantigens other than myosin have been
identified in T. cruzi-infected humans and in animal models of CHD
[5,28,29,30,31,32], but a comprehensive study of this polyantigenic
autoimmunity in a single model system has not been described.
Here, we tracked the development of autoimmunity against a panel
of known autoantigens in a single model system, comparing the
autoimmunity resulting from T. cruzi infection and immunization
with heat-killed T. cruzi (HKTC). This approach allowed us to
confirm the hypothesis that HKTC immunization can induce
autoreactive responses to antigens other than myosin, and to
analyze qualitative and quantitative differences in the type and
magnitude of humoral and cellular autoimmunity induced by
exposure to T. cruzi antigens or to an active infection. Specifically,
we assessed Th1 and Th17 responses in T. cruzi-infected and
HKTC-immunized mice, since Th1 cells are important for clearing
T. cruzi infection and both Th1 and Th17 cells are known to drive
the development of a number of autoimmune diseases
[23,33,34,35,36,37,38]. We also employed a more sensitive assay
to measure cardiac injury than had been used previously in
experiments involving T. cruzi lysate immunization, Because
immunization with T. cruzi proteins may induce cardiac injury that
is of physiological relevance despite the absence of observable
cardiac inflammation, we employed a sensitive assay to assess
cardiac injury by measuring cardiac troponin I (cTnI) [39,40].
Results
Immunization with heat-killed T. cruzi induces acute
cardiac damage without myocarditis
Infection of A/J mice with T. cruzi Brazil strain results in the
development of inflammatory myocarditis characterized by mono-
nuclear cell infiltration, edema, and myocyte degeneration. We
compared myocardial histology from mice infected with parasites to
those immunized with heat-killed T. cruzi epimastigotes (HKTC) at
days 7, 14, and 21 post infection/immunization, and assessed
HKTC-immunized mice for signs of histological disease at days 28
and 60 days post-immunization. Similar heat-killed preparations of
L. amazonensis (HKLA), a related organism with many shared
antigens, yet not known to cause cardiac pathology, were used as a
negative control to demonstrate specificity of the response. Because
the protein expression patterndiffers among T. cruzi life cyclestages,
we also immunized mice with HKTC made from tissue culture-
derived trypomastigotes (HKTCtct)a n din vitro cultured-derived
metacyclic trypomastigotes (HKTCcmt) to verify that immunization
with these more clinically-relevant life cycle forms produced a
similar results (Fig. 1A and B). To address the possibility that
contaminating antigens from the rat cardiac myocytes used to
propagate the T. cruzi trypomastigotes was contributing to the
resulting autoimmunity and inflammation, we immunized control
mice with parasite-cleared supernatants of from infected cultured
H9C2 myocytes (Fig. 1B). We found that only T. cruzi-infected mice
developed significant myocarditis, characterized by mononuclear
cell infiltration, myocyte necrosis, and edema (Fig. 1A), while
HKTC-immunized,HKLA-immunized,andPBS-immunizedmice
did not develop signs of myocarditis through 60 d.p.i., and
HKTCtct-immunized, HKTCcmt-immunized, and supernatant-
immunized mice did not show signs of cardiac inflammation when
assessed at 21 d.p.i. (Fig. 1A and B). The average inflammatory
response was quantified over time (Fig. 1B), revealing that T. cruzi-
infected mice developed progressive myocarditis from day 7
onward, with death occurring around day 25.
We next assessed acute cardiomyocyte damage, as measured by
serum cardiac troponin I (cTnI) levels. Elevated cTnI levels were
detectable in infected mice as early as 7 d.p.i. (Fig. 1C) and steadily
increased through day 21 (Fig. 1C). Importantly, immunization
with HKTC also resulted in a statistically significant elevation of
cTnI by 7 d.p.i., which persisted through 21 d.p.i. (Fig. 1C), when
compared to PBS-immunized controls.
HKTC-immunized mice develop humoral autoimmunity
with similar antigen specificity as T. cruzi-infected mice
T. cruzi-infected mice develop polyantigenic humoral reactivity,
therefore we hypothesized that HKTC immunization would
induce humoral autoimmunity to a number of autoantigens in
addition to myosin. We examined total serum reactivity against
whole heart homogenates by immunoblot, and found that both T.
cruzi-infected and HKTC-immunized mice developed immunore-
activity to an array of cardiac proteins by 21 d.p.i. (data not
shown). To obtain a quantitative measure of antibody production
and track the temporal development of humoral autoimmunity
against a panel of known cardiac autoantigens, we performed
ELISAs comparing sera from T. cruzi–infected and HKTC-
immunized mice (Table 1). Although there was a slight delay in the
development of some of the autoantibody responses in HKTC-
immunized mice (data not shown), by 21 d.p.i. both groups of mice
developed significant autoreactivity against antigens abundant in
the heart: actin, Cha antigen, desmin, laminin, myoglobin,
myosin, and tropomyosin (Fig. 2). There was no detectable
response against lung-derived elastin or stomach-derived mucin in
any of the groups (Fig. 2), suggesting a cardiac specificity to the
autoimmunity. There was no significant difference in the antibody
titers between these two groups for any of the antigens except for
myosin. As expected, both groups mounted a significant response
against HKTC (Fig. 2), and there were no significant autoantibody
responses in the HKLA-immunized mice (data not shown).
The IgG2a/IgG1 ratio of the antibody response against a
panel of cardiac antigens is higher in T. cruzi-infected
mice than in HKTC-immunized mice
To assess qualitative differences in humoral autoimmunity
between T. cruzi-infected and HKTC-immunized mice, we
examined the IgG isotypes of antigen-specific antibodies in the
two groups, and compared these responses to those of PBS-injected
control mice. Of note, the total IgG titers were similar, however, we
focused on IgG1 and IgG2a because these two isotypes account for
90% of the IgG produced in Chagas patients, and are most
associated with differential immune responses; IgG1 is associated
with a dominant Th2 response and IgG2a is associated with a
dominant Th1 response [41]. Using ELISA, we determined that
both T. cruzi-infected and HKTC-immunized mice developed
significant IgG1 and IgG2a responses to most of the antigens tested
(actin, Cha antigen, desmin, laminin, myoglobin, myosin, tropo-
myosin, and HKTC) which the PBS-immunized control animals
lacked (Table 2). In general, the infected animals had significantly
greater titers of both IgG2a and IgG1 than did HKTC-immunized
mice (Fig. 2). We next calculated the IgG2a/IgG1 ratio of the
autoantibody responses to determine whether HKTC immuniza-
tion recapitulated the IgG isotype profile induced by T. cruzi
infection, and discovered a striking difference between infected and
immunized animals. The infected animals demonstrated an IgG
response skewed toward IgG2a to 5 out of 7 autoantigens as well as
against HKTC, while HKTC-immunized animals developed a
T. cruzi-Induced Autoimmunity
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myosin. Importantly, there was a distinct difference in the IgG2a/
IgG1 ratio between the two groups: the average IgG2a/IgG1 ratio
was 4.1 in T. cruzi–infected mice and 1.1 in HKTC-immunized
mice (Table 2). These findings coincide with published reports that
T. cruzi-infected humans and mice mount a type I immune response
[42,43,44] and indicate that the HKTC-immunized mice mount a
balanced Th1/Th2 autoimmune response.
T. cruzi-infected and HKTC-immunized mice develop
cellular autoimmunity
We next investigated whether T. cruzi-infected and HKTC-
immunized mice develop cellular autoimmunity to a similar panel
of antigens by assessing DTH responses, a well-established and
sensitive measure of in vivo cellular immunity. Both infected and
immunized mice developed significant DTH responses to most of
the heart-abundant antigens, but not the non-cardiac antigens
(Fig. 3A). However, for all of the autoantigens, the response in
infected mice was significantly higher than the corresponding
response in HKTC-immunized mice. This suggests that infected
mice mount a more robust cell-mediated autoimmune response
than mice immunized with HKTC, while there is no statistically
significant difference in the anti-parasite DTH responses between
the two groups. As expected, HKLA-immunized mice only
developed significant DTH responses to parasite proteins but
not against any of the autoantigens tested (Fig. 3A). There was
crossreactivity between HKTC and HKLA in the infected and
immunized mice, which is not surprising due to the close
relationship between these two protozoans (Fig. 3A). To determine
whether immunization with HKTC made from different life-cycle
stages of the parasite results in differential induction of myosin-
specific and HKTC-specific cellular immune responses, we
immunized mice with HKTCtct and HKTCcmt, and assessed
DTH responses against HKTC, and against cardiac myosin as an
indicator of autoantigen-specific responses. There was no
significant difference in the magnitude of DTH response to
HKTC or cardiac myosin between mice immunized with HKTC,
HKTCtct, or HKTCcmt.; although HKTCcmt induced slightly
lower DTH responses against HKTCtct and myosin than the other
HKTC preparations (Fig. 3B). Overall, these results demonstrate
that immunization with T. cruzi proteins from epimastigotes, tissue
culture-derived trypomastigotes, and culture-derived metacyclic
trypomastigotes induce autoreactive cellular immune responses
that are of similar antigen specificity but lower magnitude
compared to the response that develops in T. cruzi-infected mice.
A higher proportion of splenocytes produce IFN-c in
response to autoantigens and HKTC in T. cruzi infected
mice than in HKTC-immunized mice
We hypothesized that infected mice would produce a more
dominant Th1 response than HKTC-immunized mice, based on the
observations that infected mice displayed a higher antigen-specific
IgG2a/IgG1 ratio. To characterize and compare the relative
contributions of Th1, Th2, and Th17 cells, we measured IFN-c,
IL-4, and IL-17, respectively. Due to the in vitro cytotoxicity of whole
cardiac myosin [23], we stimulated cultured cells with an
immunodominant recombinant fragment of cardiac myosin, Myo 4
[23], to assess myosin-specific cytokine responses. Significant
numbers of cells producing IFN-c a n dI L - 4i nr e s p o n s et om o s to r
all of the experimental autoantigens were isolated from the spleens of
T. cruzi-infected and HKTC-immunized mice (Fig. 4). Modest, but
statistically significant, numbers of splenocytes producing IL-17 in
response to all of the autoantigens tested were detected in infected
mice, but no significant IL-17 response was detected in the bulk
splenocyte preparation from HKTC-immunized mice (Fig. 4). The
frequency of IFN-c producing cells in infected mice was, on average,
5.2-fold higher than the frequency of cells producing IL-4, and
approximately 16-fold higher than the frequency of cells producing
Figure 1. Immunization with heat-killed T. cruzi causes acute cardiac damage but not myocarditis. A/J mice were infected with T. cruzi,
immunized with heat-killed T. cruzi epimatigotes (HKTC), T. cruzi tissue-culture trypomastigotes (HKTCtct) T. cruzi cultured metacyclic trypomastigotes
(HKTCcmt) or injected with PBS. (A) One representative image from each group at 21 d.p.i. is shown. (B) The mean histopathology score for
inflammation is indicated. For 7, 14, and 21 d.p.i., n=10 for all groups; for 28 d.p.i. n=5 for HKTC-immunized, heat-killed L. amazonensis (HKLA)-
immunized, and PBS-immunized groups. (C) The mean serum cTnI level is indicated, n=4 for T. cruzi-infected and PBS-immunized groups; n=6 for
the HKTC-immunized group. (B and C) Error bars indicate SEM. * P,0.05 compared to the PBS control group. { T. cruzi-infected mice were not
analyzed at this time point because they do not survive past 25 d.p.i.
doi:10.1371/journal.pone.0014571.g001
Table 1. A number of cardiac proteins have been identified as targets of autoimmunity in humans patients with and experimental
models of Chagas heart disease.
Protein Immunological relevance
Actin autoantibodies induced in T. cruzi-infected mice
a
Cha reactivity from human Chagasic sera and from sera and T cells in T. cruzi-infected mice
b
Desmin autoantibodies induced in T. cruzi-infected mice
c
Laminin reactivity from human Chagasic sera and from sera and T cells in T. cruzi-infected mice
d
Myoglobin autoantibodies induced in T. cruzi-infected mice
c
Myosin autoantibodies and T cell responses in T. cruzi-infected mice
b,c,e
Tropomyosin autoantibodies induced in human patients
aBALB/c x C57Bl/6,
bC57Bl/6,
cCBA/J,
dBALB/c,
eA/J.
doi:10.1371/journal.pone.0014571.t001
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frequency of the autoantigen-specific IFN-c responses in HKTC-
immunized mice were, on average, only 2.2-fold higher than the IL-4
responses, with the exception of the desmin-specific response which
was approximately 10-fold higher. Most interestingly, the frequency
of autoantigen-specific IFN-c-producing cells in infected mice
averaged 4.8-fold higher than in HKTC-immunized mice. The
frequency of autoreactive IL-4 producing cells was similar in both
groups, with the exception of the desmin-specific response, which was
markedly higher in infected mice. HKLA-immunized produced a
significant IFN-c and IL-4 response against HKLA, but not against
any other antigens. These observations suggested that, in response to
both autoantigens and HKTC, T. cruzi–infected mice mount a
dominant Th1 response with a lesser Th17 component, whereas the
immune response of HKTC-immunized mice is only slightly shifted
toward Th1 from Th2 and lacks a significant Th17 component.
T. cruzi-infected mice produce higher frequencies of
IFN-c and IL-17 single positive and IFN-c
+ IL-17
+ double
positive T cells than HKTC-immunized mice
Because both CD4+ T helper cells and other cell types including
some CD8+ T effector cells produce IFN-c and IL-17, we analyzed
cytokine production specifically from CD90+CD4+ lymphocytes via
flow cytometry to determine the relative contribution of Th1, Th2,
Figure 2. Development of humoral autoimmunity in mice immunized with HKTC is of similar antigen specificity as in T. cruzi
infected mice. A/J mice were infected with T. cruzi (n=7), immunized with HKTC (n=7), or injected with PBS (n=3). ELISA analysis was used to test
individual serum samples for IgG reactivity to T. cruzi as well as to a panel of cardiac antigens (actin, Cha antigen, desmin, laminin, myoglobin, myosin,
tropomyosin) and non-cardiac antigens (elastin, mucin) or the immunologically irrelevant antigen BSA at 21 d.p.i. Each data point represents the
mean antibody titer of each cohort above the background response to BSA. Error bars indicate SEM. Data are representative of two independent
experiments. * P,0.05.
doi:10.1371/journal.pone.0014571.g002
Table 2. The cardiac antigen-specific IgG2a/IgG1 antibody isotype ratio is higher in T. cruzi-infected mice than in HKTC-immunized
mice.
T. cruzi-Infected Mice HKTC-Immunized Mice PBS-Immunized Mice
IgG2a IgG1
G2a:
G1 IgG2a IgG1 G2a:G1 IgG2a IgG1 G2a:G1
GMT
Log2±
SE
a GMT
Log2±
SE Ratio GMT
Log2±
SE GMT
Log2±
SE Ratio GMT
Log2±
SE GMT
Log2±
SE Ratio
actin 174.1 7.460.2
a 126.0 7.060.2
a 1.1 69.6 6.161.8
a 51.7 5.760.6
a 1.1 1.0 0.060.8 2.2 1.161.2 --
Cha 696.4 9.460.2
a 2.2 1.161.1
a 8.5
b 253.9 8.060.4
a 21.6 4.460.4
a 1.8
b 2.2 1.161.2 1.0 0.060.8 --
desmin 7351.7 12.860.2
a 4.6 2.261.4
a 5.8
b 200.1 7.661.3
a 119.4 6.960.8
a 1.1 1.0 0.060.8 1.0 0.060.8 --
laminin 919.0 9.860.2
a 5079.7 12.360.8
a 0.8
b 17.6 4.161.3
a 39.8 5.360.8
a 0.8 2.2 1.161.2 1.0 0.060.8 --
myog-
lobin
174.1 7.460.2
a 112.2 6.860.2
a 1.1
b 95.1 6.660.2
a 143.1 7.260.9
a 0.9 1.0 0.060.8 2.2 1.161.2 --
myosin 3687.5 11.860.2
a 712.7 9.560.3
a 1.2
b 517.8 9.060.2
a 159.0 7.360.5
a 1.2
b 2.2 1.161.2 2.2 1.161.2 1.0
tropo-
myosin
4222.4 12.060.5
a 141.4 7.160.2
a 1.7
b 293.1 8.260.2
a 263.3 8.060.7
a 1.0 1.0 0.060.8 1.0 0.060.8 --
HKTC 12800.0 13.660.0
a 2.2 1.161.1
a 12.4
b 3665.8 11.860.9
a 7311.9 12.860.8
a 0.9 4.6 2.261.5 4.6 2.261.5 1.0
Mean 4.1 1.1
All analyses were conducted at 21 days post-infection. n=5 for each group except n=3 for PBS-immunized group. GMT, geometric mean titer.
aP,0.05 compared to the PBS/CFA-immunized control group.
bP,0.05 for the IgG2a response compared to the corresponding IgG1 response for each cohort.
doi:10.1371/journal.pone.0014571.t002
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CD90+CD4+ T cells producing IFN-c, IL-4, and IL-17 when
stimulated with a polyclonal T cell activator was significantly
increased in T. cruzi-infected mice relative to PBS-immunized control
mice (Fig. 5A). The percentage of IFN-c
+ cells was nearly two-fold
greater than the percentage of IL-4
+ cells, consistent with our earlier
findings that suggested T. cruzi-infected mice mount a Th1-dominant
immune response. HKTC-immunized mice produced slightly
increased levels of IFN-c- and IL-17-producing CD90+CD4+ T
cells relative to PBS-immunized controls; however this increase was
not statistically significant, (p=.086 and .079, respectively). HKTC-
immunized mice also did not develop an increased percentage of IL-
4
+ CD90+CD4+ T cells. The frequency of IFN-c
+ and IL-17
+ cells in
HKTC-immunized mice was significantly lower than in T. cruzi-
infected mice, while there was no significant difference in the levels of
IL-4+ cells. We further analyzed the IFN-c
+ and IL-17
+ cells to
determine whether these findings were entirely attributable to
increased frequencies of IFN-c and IL-17 single-positive populations,
representing traditional Th1 and Th17 cells, respectively, or if T.
cruzi-infected or HKTC-immunized mice developed increased
frequencies of the more recently described IFN-c
+IL-17
+ double
positive population. Becauseincreases in the frequencies of IFN-c
+IL-
17
+ have been positively correlated with disease severity in several
models of inflammatory and autoimmune diseases, we hypothesized
that the decreased total numbers of IFN-c
+ and IL-17
+CD90+CD4+
T cells in HKTC-immunized mice, relative to T. cruzi-infected mice,
might be partially attributable to a decrease in this IFN-c+IL-17+
population. We found that T. cruzi-infected mice produced
significantly increased percentages of IFN-c+IL-17-, IFN-c
2IL-17
+,
and IFN-c
+IL-17
+ cells compared to control mice (Fig. 5B). HKTC-
immunized mice produced similar frequencies of IFN-c
2IL-17
+ and
IFN-c
+IL-17
+ cells as control mice, and a slight but not significant
increase in IFN-c
+IL-17
+ cells (p=.066) (Fig. 5B). The difference in
frequencies of IFN-c
+IL-17
2 between HKTC-immunized and T.
cruzi-infected mice strongly trended towards significance (p=.058),
and the difference in frequencies of IFN-c
2IL-17
+ and IFN-c
+IL-17
+
were significant. These results support our hypothesis that HKTC-
immunization does not induce the same type (Th1-skewed) of
immune response that develops in response to T. cruzi infection.
Figure 3. T. cruzi-infected and HKTC-immunized mice develop DTH specific for a number of cardiac and non-cardiac proteins. A/J
mice were infected with T. cruzi, immunized with HKTC, immunized with HKLA, or injected with PBS. (A) At 21 d.p.i., antigen-specific DTH responses to
a panel of cardiac and non-cardiac antigens were measured by a standard 24-hour ear swelling assay. (B) DTH responses specific for HKTC and myosin
were measured in A/J mice immunized heat-killed T. cruzi epimatigotes (HKTC), T. cruzi tissue-culture trypomastigotes (HKTCtct) T. cruzi cultured
metacyclic trypomastigotes (HKTCcmt), supernatant from T. cruzi-infected myoblast cultures (supernatant), or injected with PBS. Data represent the
net ear swelling response over the basal response to an irrelevant antigen (BSA). Error bars indicate SEM (n=4). Data are representative of two
independent experiments. * P,0.05 compared to the PBS control group.
doi:10.1371/journal.pone.0014571.g003
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concentrations than HKTC-immunized mice
Because IL-12 is important for promoting differentiation of and
IFN-c production by Th1 cells, we investigated whether the difference
in the magnitude of Th1 immune responses between T. cruzi-infected
a n dH K T C - i m m u n i z e dm i c ei sa s s o c i a t e dw i t had i f f e r e n c ei nI L - 1 2
levels. Serum was collected from T. cruzi-infected, HKTC-immunized
mice,and HKTCtct-immunized mice at 21 d.p.i., and measured IL-12
concentrations via ELISA. T. cruzi-infected mice had serum IL-12
levels that were approximately two-fold higher than mice immunized
with HKTC or HKTCtct. The serum IL-12 concentrations of the
HKTC-immunized mice and HKTCtct-immunized mice were not
significantly different from PBS-immunized mice (Figure 6).
Discussion
Previously, we found that immunization with T. cruzi protein
extract in CFA induced a robustmyosin-specific humoral and cellular
autoimmune response, similar to that observed in T. cruzi-infected
mice. However, the T. cruzi protein-immunized mice did not develop
significant cardiac histopathology nor did they experience early
mortality, suggesting that myosin-autoimmunity alone was not
sufficient to induce myocarditis. T. cruzi-infected mice are known to
develop autoimmunity against numerous non-myosin cardiac
antigens, but it was not known whether the autoreactive responses
elicited by T. cruzi immunization extended to any antigens aside from
myosin. In the present study we sought to determine whether the
autoreactive immunity induced by immunization with whole HKTC
extended to non-myosin antigens, and to analyze the autoimmunity
induced by HKTC immunization and T. cruzi infection to elucidate
any qualitative or quantitative differences that may account for the
absence of myocarditis. HKTC was initially prepared from T. cruzi
epimastigotes for most studies due to the comparative ease of
generating the large numbers needed for immunization, and to avoid
the potential contamination of trypomastigotes preparations with
antigens from the rat cardiac myocytes used to propagate these cells.
Subsequent analysis demonstrated that the autoimmunity and
cardiac damage resulting from HKTC immunization was similar
when tissue culture trypomastigotes or culture metacyclic trypomas-
tigotes were used for HKTC production instead of epimastigotes,
validating the clinical relevance of the epimastigote HKTC
experimentation.
Figure 4. Splenocytes from T. cruzi-infected mice produce a different cytokine profile when stimulated with cardiac autoantigens
than those from HKTC-immunized mice. A/J mice were infected with T. cruzi, or immunized with HKTC, HKLA, or PBS. At 21 d.p.i., splenocytes
were isolated and combined from five mice per group and stimulated with the indicated antigens. (A) IFN-c, (B) IL-4, and (C) IL-17 production were
measured by ELISPOT. Data are representative of four independent experiments. Error bars indicate SEM (n=4). * P,0.05 compared to the PBS
control group.
doi:10.1371/journal.pone.0014571.g004
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is a widely used indicator of cardiac injury. It has been previously
validated in a murine model of experimental autoimmune
myocarditis, and demonstrates greater utility than creatine kinase
or anti-cardiac myosin antibodies [45,46,47,48,49]. Increased
serum cTnI levels positively correlate with increased levels of
histopathological changes in the myocardium, and serum markers
are a facile means of tracking cardiac injury [47]. T. cruzi-infected
A/J mice developed a progressive myocarditis that correlates with
rising serum cTnI. Interestingly, we found that HKTC immuni-
zation also resulted in a statistically significant increase in serum
cTnI. Not surprisingly, given the extensive myocarditis and
myocyte necrosis present in the hearts of infected mice compared
to the lack of inflammatory cell infiltrate and necrosis in the hearts
Figure 5. T. cruzi-infection but not HKTC immunization induces robust autoreactive Th1 and Th17 responses. A/J mice were infected
with T. cruzi (INF), or immunized with HKTC (HKTC), or PBS (PBS). At 21 d.p.i., splenocytes were isolated and stimulated with HKTC or Myo 4.
Intracellular cytokine staining of CD90+CD4+ splenocytes stimulated with anti-CD3 for IFN-c, IL-4, and IL-17 was analyzed via flow cytometry. (A) The
mean percentage of cytokine-positive cells is shown. Error bars indicate SEM (n=4 for INF and HKTC; n=3 for PBS). Data are representative of two
independent experiments. (B) Representative plots of the cells quantified in panel A are shown. The mean percentage and SEM of IFN-c+IL-17-, IFN-
c+IL-17+, and IFN-c2IL-17+ cells are indicated.
doi:10.1371/journal.pone.0014571.g005
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lower in the HKTC-immunized animals. However, because
elevated serum cTnI is such a sensitive and specific measure of
cardiac damage, this strongly suggests that HKTC is initiating
sustained cardiac damage in association with induction of
polyantigenic autoimmunity, which has not been previously
reported [50]. It is also possible that T. cruzi-infected mice and
HKTC-immunized mice produce autoantibodies against cTnI,
which is not unlikely given the observed polyantigenic humoral
immune response in these mice. The presence of autoantibodies
against troponins in human patients that have experienced
myocardial injury has been reported by several groups, and it
has been demonstrated that the presence of these antibodies may
cause false lower levels of cTnI release, especially when measured
by an immunoassay such as that employed in our studies [51].
This may explain why we did not measure higher levels of cTnI in
infected and immunized mice, and we will test this possibility in
the future. Importantly, this result indicates that parasite antigens
alone can initiate cardiac damage leading to subsequent
polyantigenic autoimmunity.
The observation that HKTC immunization results in acute
myocardial damage and autoimmunity, but not myocarditis, led us
to hypothesize that a difference existed in the type or magnitude of
cardiac autoimmunity induced by T. cruzi infection and HKTC
immunization that led to different disease outcomes in the two
groups. We determined that both T. cruzi infection and HKTC
immunization induce cardiac-specific humoral autoreactivity of
similar antigen-specificity against the specific proteins in Table 1,
with no significant difference in antibody titers specific for any
antigen except for myosin, suggesting that the presence of
autoimmunity alone does not determine disease outcome. We
next analyzed the isotype profiles of the autoantibody responses to
determine whether the types of antibodies produced during T.
cruzi infection differed from those induced by HKTC immuniza-
tion. We found that the IgG isotype ratio in infected mice was
highly skewed toward IgG2a, while the ratio of IgG2a to IgG1 was
nearly equivalent in HKTC-immunized mice. This suggested that
T. cruzi-infected mice produced large amounts of IFN-c
+ cells in
relation to IL-4
+ cells, consistent with a Th1-dominant immune
response, whereas HKTC-immunized mice mounted a more
balanced Th1/Th2 response.
There is controversy over what T cell subtype(s) drives the
autoimmune response in experimental CHD. Th1 cells play an
essential role in mediating parasite clearance in T. cruzi-infected
mice by promoting the expansion and functions of CD8+ effector
T cells [33]; however, this response also leads to tissue destruction
and ongoing release of host antigens. [52]. Th1 cells are known to
drive the pathogenesis of a number of autoimmune diseases, so it is
likely that Th1 cells contribute to cardiac autoimmunity in CHD
[34,35,36,37]. Th17 responses have also been linked to the
pathogenesis of a number of inflammatory and autoimmune
diseases, including EAM and experimental autoimmune enceph-
alomyelitis (EAE) [23,36,37,38] and, in fact, a combination of both
cell subtypes contributes to the inflammation in many of those
models. However, there is evidence that IL-17 plays an anti-
inflammatory role during T. cruzi infection by indirectly down-
regulating the functions of pro-inflammatory Th1 cells through an
IL-12 and T-bet dependent mechanism [53]. Recently, the
collective understanding of how Th1 and Th17 cells might play
distinct roles in clearing infections and mediating inflammatory
conditions has been complicated by the observation of a
subpopulation of CD4+ T cells that simultaneously produce both
IFN-c and IL-17 in certain circumstances, such as in mouse
models of EAE and in the coronary arteries of human
atherosclerotic patients, and increases in IFN-c
+IL-17
+ have been
correlated with increased pathology [54,55,56].
Measurement of the frequencies of autoreactive IFN-c
+, IL-4
+,
and IL-17
+ splenocytes from T. cruzi-infected and HKTC-
immunized mice confirmed the hypothesis that infected mice
mounted an immune response skewed toward IFN-c, the
prototypic Th1 cytokine. The frequency of autoantigen-specific
IFN-c-producing cells in the spleens of infected mice was
significantly higher than the frequency of cells producing IL-4 in
response to the same antigens for 6 of 7 antigens. In HKTC-
immunized mice, the frequency of autoantigen-specific IFN-c-
producing cells was significantly higher than the corresponding
frequency of IL-4 producing cells only for 3 of 7 antigens, and for
2 of 7 antigens the frequency of IL-4 producing cells was higher. T.
cruzi-infected mice also generated a significant amount of
autoreactive IL-17 positive cells specific for all 7 autoantigens
tested, but a significant number of IL-17
+ cells were not detected
in the HKTC-immunized mice in response to these antigens. This
suggested that infected mice produced a dominant Th1 response,
but HKTC-immunized mice did not, which might account for the
lack of myocarditis in HKTC-immunized mice. These results also
correlated with the observation that T. cruzi-infected mice
developed more robust antigen-specific DTH responses than
HKTC-immunized mice, reflecting the overall trend than infected
Figure 6. T. cruzi-infected mice have higher serum IL-12 than do HKTC-immunized mice. A/J mice were infected with T. cruzi (INF),
immunized with epimastigote HKTC (HKTC), trypomastigote HKTC (HKTCtct) or PBS (PBS). At 21 d.p.i., sera was collected and IL-12 levels were
measured via ELISA. The mean concentration of serum IL-12 is shown. Error bars indicate SEM (n=8 for INF; n=7 for other groups). * P,0.05
compared to the PBS control group.
doi:10.1371/journal.pone.0014571.g006
T. cruzi-Induced Autoimmunity
PLoS ONE | www.plosone.org 9 January 2011 | Volume 6 | Issue 1 | e14571mice have a more highly-activated T cell compartment than
HKTC-immunized mice.
To specifically assess the relative contribution of Th1, Th2, and
Th17 cells to the observed immunity, CD90+CD4+ splenic T
helpercellswere analyzedvia flow cytometryforproduction ofIFN-
c, IL-4, and IL-17, respectively. We found significantly increased
percentages of Th1, Th2, and Th17 cells in infected mice relative to
PBS-immunized control mice, reflective of a global expansion of Th
cells in response to active T. cruzi infection. Th1 cells predominated
and were nearly twice as abundant as Th2 cells, consistent with our
hypothesis and previous reports that T. cruzi-infection induces
robust Th1 immunity. Although Th1-dominace was verified, the
ratio of Th1 to Th2 cells was somewhat decreased compared to the
ratio of IFN-c
+ to IL-4
+ antigen-specific bulk splenocytes, most
likely due to the contribution of other effector cells such as CD8+
cytotoxic T cells to the total
IFN-c response. A significant Th17 response in infected mice
became apparent when analysis was restricted to CD90+CD4+ T
cells instead of bulk splenocytes, likely because the greatest
proportion of IL-17
+ cells were CD4+ Th17 cells. Although there
was a trend towards significance in the frequency of Th1 and Th17
cells in HKTC-immunized mice relative to control mice, this
increase was not significant, and there was also no significant
increase in Th2 responses, despite the detection of significant levels
of IFN-c
+ and IL-4
+ antigen-specific bulk splenocytes in mice
immunized with HKTC. These ambiguous results may reflect the
contribution of other cell types to the production of these cytokines.
IL-12 is a cytokine known for its important role in driving Th1-
differentiation of naı ¨ve CD4+ T cells and promoting IFNc-
production of CD4+ T cells [57,58]. We proposed that the
magnitude of the IFNc response in T. cruzi-infected and HKTC-
immunized mice correlated to a difference IL-12 production, and
indeed we found that T. cruzi-infected mice had IL-12 serum
concentrations that were approximately two-fold higher than mice
immunized with HKTC or HKTCtct. Further experimentation
will be necessary to link this association to causation regarding the
role of IL-12 in the pathogenesis of CHD, and to assess the kinetics
of IL-12 production in T. cruzi-infected and HKTC-immunized
mice.
Separate from the question of whether T. cruzi-induced
autoimmunity is necessary or sufficient to induce myocarditis is
the question of how autoimmunity develops as a result of exposure
to T. cruzi antigens. The observation that acute cardiac injury and
cardiac autoimmunity develop in response to HKTC immuniza-
tion in the absence of live parasites suggests that molecular
mimicry likely initiates exposure to cardiac antigens, thus
promoting the development of cardiac specific immune responses
during T. cruzi infection [27,59,60,61,62]. Several specific T. cruzi
proteins have already been identified as mimics of mammalian
proteins, including B13 [60] and cruzipain [4] which are mimics of
cardiac myosin, and T. cruzi ribosomal P proteins which mimic b1
adrenoreceptors [63]. To evaluate the possibility that our HKTC
preparation is directly cardiotoxic, leading to cardiac antigen
(including cTnI) release and induction of autoimmunity, we
assessed HKTC toxicity to cultured myoblasts in vitro by measuring
mitochondrial reductase activity via an MTT assay as a surrogate
of viability (data not shown). We found that neither HKTC nor
HKLA caused significant loss of viability, which suggests, along
with the temporal kinetics of the response, that myocardial
damage in HKTC-immunized mice is mediated by an immune
mechanism such as molecular mimicry, rather than the result of
direct HKTC cellular toxicity.
Many of the aforementioned experiments were conducted using
HKTC made from T. cruzi epimastigotes, which is the life cycle
form of the parasite that replicates inside the insect vector, due to
the relative ease of propagating this life cycle stage, and to avoid
concerns of potential contamination by antigens from the
myocytes used to propagate trypomastigotes. Since epimastigotes
do not cause disease, we compared the cell-mediated and humoral
immunity, and myocarditis that develops following immunization
with HKTC made from other, more clinically relevant life cycle
stages. No significant differences in the induction of T. cruzi-
specific or autoantigen-specific DTH or antibody responses were
observed in mice immunized with HKTC made from epimasti-
gotes HKTC, tissue culture-derived trypomastigotes (surrogate for
bloodform trypomastigotes), or in vitro culture-derived metacyclic
trypomastigotes. Similar to epimastigote HKTC, HKTC made
from the other two life cycle stages did not induce cardiac
inflammation or myocyte necrosis. This suggests that our
observations are attributable to autoimmunity initiated by antigens
conserved among these three life cycle stages of T. cruzi.
In order for HKTC immunization to result in autoimmunity
involving all seven of the autoantigens described in this paper, one
of the following scenarios likely occurs: (i) a number of
independent molecular mimicry events occurred involving epi-
topes of T. cruzi antigens initiating cross-reactive responses against
one or more epitopes found in each of these autoantigens, or (ii)
molecular mimicry occurs between one or a few T. cruzi antigens
and cardiac proteins and the specificity of the autoimmune
response expands via epitope spreading. Given that molecular
mimicry is a relatively uncommon and restricted event, we favor
the latter explanation. Epitope spreading, which occurs when an
initial immune response targeting one antigen causes tissue
damage precipitating the release of other self-antigens and
generating a cascade of additional, non-cross-reactive autoimmune
responses, has already been implicated in the pathogenesis of a
number of autoimmune diseases [64,65,66,67] and may be
involved in propagating the autoimmunity characteristic of
CHD, irrespective of the initial cause. We hypothesize that
molecular mimicry does occurs between a limited number of T.
cruzi antigens and structurally related host proteins, initiating
immune responses that result in cardiac damage, as evidenced by
troponin release, and that epitope spreading then broadens the
spectrum of autoimmunity. These mechanisms occur in concert
with other immune mechanisms to contribute to the overall
autoimmunity and pathogenesis of CHD, as described in recent
reviews [1,7,68]. We are currently exploring novel molecular
mimicry candidates and further investigating epitope spreading in
experimental CHD.
An increasingly popular hypothesis suggests that microbial
infections, by inducing production of a milieu of proinflammatory
cytokines and other factors, can induce autoreactive T cells to
become ‘‘autoaggressive’’ effectors and exact pathological damage
[69]. In several models of pathogen-associated autoimmune
diseases, adjuvants such as CFA appear capable of recapitulating
this inflammatory environment and driving autoreactive T cells to
become ‘‘autoaggressive,’’ but in other cases more complex stimuli
such as the coadministration of IL-1 and TNF-a were required to
achieve this effect [69,70]. It is possible that for T. cruzi–induced
autoimmunity to cause cardiac pathology, parasite antigens must
be presented in a complex inflammatory environment such as that
which develops during active infection of the heart, which is not
well recapitulated by the addition of adjuvant in the peripheral
subcutaneous depot.
This study unifies the characterization of polyantigenic cardiac
autoimmune responses following T. cruzi infection and exposure to
heat-killed parasites. In both scenarios acute cardiac damage
occurs, but only active infection resulted in the development of
T. cruzi-Induced Autoimmunity
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immune response is different, especially when the immunoglobulin
subclasses and cytokine profiles are compared, even if the
quantitative measures of autoimmunity are similar. We conclude
that the specific immunological differences resulting from an active
infection versus an immunization are critical to development of
myocarditis, and that autoimmunity resulting from heat-killed T.
cruzi immunization is insufficient to induce myocarditis in A/J
mice. We propose that a dominant Th1 response may be critical to
the immune response generated during T. cruzi infection that is
essential for tissue inflammation.
Materials and Methods
Experimental animals, infections and immunizations
Male A/J mice (Jackson Laboratories, Bar Harbor, ME) were 4
to 6 wk of age at the time experiments were initiated. Mice were
anesthetized by a single intraperitoneal injection of avertin,
240 mg/kg of body weight for each experimental manipulation.
A cardiotropic substrain of the Brazil strain of T. cruzi (Brazil
Heart) generated in our laboratory [71] was propagated in H9C2
rat myoblasts to generate trypomastigotes for infection and for
production of HKTCtct. Mice were infected by intraperitoneal
injection of 1610
4 Brazil heart strain trypomastigotes in
Dulbecco’s phosphate-buffered saline (PBS; GibcoBRL, Grand
Island, NY) or injected with PBS alone (controls). Leishmania
amazonensis promastigotes (clone LV 78) were maintained in
medium 199 (Gibco BRL, Grand Island, N.Y.) supplemented with
10% heat-inactivated fetal bovine serum (Gibco BRL) and grown
at 25uC. To produce HKTCcmt, epimastigotes were transformed
into metacyclic trypomastigotes via in vitro culture in artificial
triatomine urine medium (TAU) (190 mM-NaC1, 17 mM-KCl,
2 mM-MgCl, 2 mM-CaC12, 8 mM-potassium phosphate buffer,
pH 6.0) for 2 h, then in TAU supplemented with 10 mM glucose,
10 mM proline, 2 mM sodium aspartate, and 50 mM sodium
glutamate at 27uC as previously described [72]. For immuniza-
tions, mice were immunized with HKTC, heat-killed L. amazonensis
(HKLA), or PBS in an emulsion of CFA in a 1:1 ratio. A total
volume of 150 ml was distributed in three subcutaneous injections
in the dorsal flank. Seven days later, mice were given a booster in
an identical manner. Infected mice become moribund starting at
17 d.p.i.; 50% must be humanely sacrificed by 21 d.p.i., and 100%
by 25 d.p.i., whereas all of the HKTC-immunized and HKLA-
immunized mice survive through 60 d.p.i without loss. Mice were
housed in pathogen-free animal facilities, and the use and care of
mice were in accordance with the guidelines of the Center for
Comparative Medicine at Northwestern University.
Preparation of antigens
Total heart homogenate and cardiac myosin heavy chain were
prepared as described previously [5]. HKTC was prepared by
washing T. cruzi epimastigotes, tissue culture trypomastigotes, or
cultured metacyclic trypomastigotes three times in PBS, resus-
pending in PBS at a concentration of 6.67610
8 parasites/ml
unless otherwise noted, and incubating in an 80uC water bath for
10 min. Complete loss of viability was verified by culture of treated
parasites for 30 days in both trypomastigote and epimastigote
culture medium (DMEM and a liver digest-neutralized, tryptose
medium, LDNT). HKLA was prepared using promastigotes in a
similar manner. In both HKTC and HKLA whole parasite bodies
were observed to be uniformly intact via light microscopy. Parasite
preparations at 1610
7 parasites/ml were stored at 220uC until
use. Englebreth-Holm-Swarm murine sarcoma laminin, rabbit
skeletal muscle actin, porcine skeletal muscle tropomyosin, elastin
from mouse lung, mucin from porcine stomach, and horse heart
myoglobin were purchased from Sigma-Aldrich (Atlanta, GA).
Lyophilized proteins were resuspended at 1 mg/ml in sterile PBS.
Recombinant human Cha antigen was produced in Escherichia coli
DH5a strain transformed with the pGEX4T3-Cha plasmid
(generously provided by Manuel Fresno, Universidad Auto ´noma
de Madrid, Spain) [28]. Recombinant mouse desmin was
produced in Escherichia coli DH5a strain transformed with the
pKK25-pLysE plasmid. Recombinant Cha and desmin were
engineered with GST and hexahistidine tags, respectively, and
purified from E. coli expressors by affinity chromatography.
Purified recombinant proteins were resuspended in sterile PBS
at 1 mg/ml. For in vitro T cell stimulation, cardiac myosin was
substituted with an immunodominant portion of cardiac myosin
named Myo 4, which was produced recombinantly as previously
described and resuspended in PBS at 5 mg/ml [23].
Histopathology
Hearts were removed, washed free of blood, dried, weighed and
fixed for at least 24 hr in 10% buffered formalin. Fixed hearts
were embedded in paraffin, sectioned, stained with hematoxylin
and eosin, and examined by light microscopy. Each section was
examined for evidence of mononuclear and polymorphonuclear
cellular infiltration and was assigned a score between 0 (no
involvement) and 4 (100% involvement), with 1, 2, and 3
representing 25, 50, and 75% involvement of the histologic
section as previously described [25,73]. Six sections per heart were
analyzed at 206to determine the histopathological score.
cTnI ELISA
Serum cTnI levels in T. cruzi-infected (n=4), HKTC-immu-
nized (n=6), and PBS-immunized (n=4) mice were measured
using a high sensitivity mouse cTnI ELISA kit per manufacturer’s
instructions. (Life Diagnostics, Inc., West Chester, PA). Mouse sera
were collected at 21, 7, 14, and 21 d.p.i. and immediately stored
at 280uC until use, then thawed on ice before analysis. Serum
samples (50 ml) were diluted 1:1 with sterile PBS. All samples were
analyzed in duplicate. Absorbance was measured at 450 nm in a
Kinetic MicroPlate Reader (Molecular Devices, Sunnyvale, CA).
Detection limits were based on the linear standard curve obtained
with the cTnI standards provided in the kit.
IgG and IL-12 ELISA
Approximately 200 ml sera was collected from retro-orbital
bleed prior to sacrifice at 21d.p.i. and immediately stored at
220uC until use, then thawed on ice before analysis. Levels of
antigen-specific total immunoglobulin G (IgG), IgG1, and IgG2a
were measured by ELISA as described previously [5]. IgG
antibody titers were defined as the highest serum dilution that
produced an absorbance value at optical density of 450 nm that
was at least 2 standard deviations above the mean absorbance for
negative control samples (pooled sera from uninfected mice,
n=10) included on each plate. Levels of IL-12 were measured per
manufacturer’s instructions (Ebioscience, San Diego, CA). All
samples were analyzed in duplicate. Absorbance was measured at
450 nm in a Kinetic MicroPlate Reader (Molecular Devices,
Sunnyvale, CA). Detection limits were based on the linear
standard curve obtained with the IL-12p70 standards provided
in the kit.
Measurement of delayed-type hypersensitivity
Antigen-specific delayed-type hypersensitivity (DTH) was quan-
tified using a standard ear swelling assay [5]. Antigen-induced ear
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exhibited typical DTH kinetics (i.e., minimal swelling at 4 hr and
maximal swelling at 24 hr to 48 hr post injection). Net ear swelling
was determined by subtracting the mean swelling generated in
response to an irrelevant antigen (BSA) from the mean response
generated by the test antigen, as measured with a Mitutoyo model
7326 engineer’s micrometer (Mitutoyo MTI Corporation, Aurora,
Ill.).
ELISPOT assay
RBC-free single cell suspensions were prepared from mouse
spleens as described previously [23]. The cells were washed and
resuspended in complete DMEM (supplemented with 50 mM b-
mercaptoethanol, 10% fetal bovine serum, 2 mM L-glutamine,
0.1 M nonessential amino acids, and 100 U/ml penicillin). Cells
were plated at 5610
5 cells per well and cultured in 96-well plates
that were precoated with 2 mg/ml anti-IFN-c, anti-IL-4, or anti-
IL-17 (BD Biosciences, San Diego, CA, USA) in PBS. Cells were
stimulated with 125 mg/ml of actin, cardiac myosin (a polypeptide
named Myo 4 spanning amino acids 1074–1646) [23], Cha
antigen, desmin, laminin, myoglobin, tropomyosin, HKTC, or
BSA (negative control) and incubated at 37uCi n5 %C O 2 for
36 h. Plates were washed to remove cells and incubated with
alkaline phosphatase-conjugated anti-biotin antibody for 2 hr and
developed using 5-bromo-4-chloro-3indoyl phosphate and p-
nitroblue tetrazolium phosphate in 100 mM Tris, 1 mM MgCl2
(pH 9.5). Cytokine production was quantified using an Immuno-
spot apparatus (Cellular Technology Ltd, Shaker Heights, OH,
USA).
Intracellular cytokine staining and flow cytometric
analysis
RBC-free single cell suspensions were prepared from mouse
spleens as described previously [23]. The cells were washed and
resuspended in complete DMEM. Cells were plated at 5610
5 cells
per well and cultured in 96-well plates for 72 hr while being
stimulated with anti-CD3 (2c11 hybridoma) or BSA (Sigma-
Aldrich). Following stimulation cells were washed and re-
stimulated with 5 ng/ml phorbol 12-myristate 13-acetate (Sig-
ma-Aldrich) and 500 ng/ml ionomycin (Fisher Scientific) for 3 h,
then with 1:1000 Golgi Plug and 1:1000 Golgi Stop (BD
Biosciences) for 3 h. Cells were washed and blocked for 10 min
with 1:100 anti-CD16/32 (Ebioscience) then stained with anti-
CD90-PE-Cy7 and anti-CD4-PE-Cy5.5 (Ebioscience) for 20 min
and washed. Cells were then fixed with 4% paraformaldehyde at
4C for 20 min and permeabilized using the Perm/Wash buffer
from the BD Cytofix/Cytoperm Plus Fixation/Permeabilization
Kit (BD Biosciences). Intracellular cytokine staining was per-
formed using anti-IFN-c-FITC, anti-IL-4-APC, and anti-IL-17-PE
(BD Biosciences). Flow cytometry was performed using an LSRII
flow cytometer with FACS Diva software (Becton Dickinson,
Mountain View, CA), with a minimum of 10,000 events recorded,
and analyzed with FlowJo 7.6 Software.
Statistical analysis
DTH values and antibody titers were log2-transformed prior to
statistical analysis if they were not normally distributed. Titers of 0
were replaced by 1 for logarithmic transformations. For
comparison of two groups, significance was determined by
Student’s t test. For comparison of multiple groups and a control,
the significance was assessed by one-way analysis of variance,
followed by adjustment for multiple comparisons by the Dunnett
test (post hoc analysis). The control group for comparison is
specified in each figure legend. P values of ,0.05 were considered
significant.
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